Voloridge Investment Management LLC Sells 107,902 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Voloridge Investment Management LLC decreased its position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 38.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 171,342 shares of the financial services provider's stock after selling 107,902 shares during the quarter. Voloridge Investment Management LLC owned 0.40% of Trupanion worth $8,259,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of TRUP. Vanguard Group Inc. raised its stake in shares of Trupanion by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock worth $173,362,000 after purchasing an additional 45,653 shares during the period. Marshall Wace LLP increased its position in shares of Trupanion by 6.9% during the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider's stock valued at $43,459,000 after buying an additional 57,804 shares during the period. Balyasny Asset Management L.P. boosted its stake in Trupanion by 368.2% in the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock worth $40,548,000 after buying an additional 661,559 shares in the last quarter. Baillie Gifford & Co. lifted its position in Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after purchasing an additional 147,341 shares during the last quarter. Finally, Northern Trust Corp lifted its position in Trupanion by 9.0% in the fourth quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock valued at $17,749,000 after purchasing an additional 30,549 shares during the last quarter.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Stifel Nicolaus decreased their price objective on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a report on Thursday, February 20th. Piper Sandler cut their target price on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research note on Thursday, February 20th. Finally, Lake Street Capital cut their target price on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $51.80.

Trupanion Stock Performance

Trupanion stock traded down $0.81 during mid-day trading on Friday, hitting $47.34. The company had a trading volume of 196,549 shares, compared to its average volume of 604,764. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. Trupanion, Inc. has a 12-month low of $25.90 and a 12-month high of $57.90. The company's fifty day moving average is $39.72 and its 200-day moving average is $43.96. The company has a market capitalization of $2.03 billion, a price-to-earnings ratio of -206.07, a P/E/G ratio of 6.02 and a beta of 1.72.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.02. The company had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm's revenue for the quarter was up 11.7% on a year-over-year basis. During the same quarter last year, the firm posted ($0.16) EPS. Equities research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Insider Transactions at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 2,294 shares of Trupanion stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total value of $72,008.66. Following the completion of the sale, the chief executive officer now owns 118,784 shares in the company, valued at $3,728,629.76. The trade was a 1.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Fawwad Qureshi sold 828 shares of the company's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $45.53, for a total value of $37,698.84. Following the completion of the transaction, the chief financial officer now directly owns 6,079 shares in the company, valued at approximately $276,776.87. The trade was a 11.99% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 37,247 shares of company stock valued at $1,296,957. 5.42% of the stock is currently owned by corporate insiders.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.